Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2020 | 06-2020 | 12-2019 | 06-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,263 | -9,036 | 3,858 | -8,824 | N/A |
| Depreciation Amortization | 26 | 76 | -39 | 21 | N/A |
| Other Working Capital | -1,001 | 2,801 | -2,179 | -986 | N/A |
| Other Operating Activity | 74 | -174 | 129 | -191 | -5,142 |
| Operating Cash Flow | $5,362 | $-6,333 | $1,769 | $-9,980 | $-5,142 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -11 | -5 | -5 | -2 |
| Investing Cash Flow | $-2 | $-11 | $-5 | $-5 | $-2 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 24,992 | 2,674 | 167 | 9,099 | 102 |
| Financing Cash Flow | $24,992 | $2,674 | $167 | $9,099 | $102 |
| Exchange Rate Effect | -722 | 177 | 87 | 289 | 164 |
| Beginning Cash Position | 6,728 | 9,670 | 9,850 | 10,896 | 10,848 |
| End Cash Position | 25,633 | 6,176 | 8,330 | 10,299 | 5,969 |
| Net Cash Flow | $18,906 | $-3,494 | $-1,519 | $-598 | $-4,879 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,362 | -6,333 | 1,769 | -9,980 | -5,142 |
| Free Cash Flow | 5,362 | -6,333 | 1,769 | -9,980 | -5,142 |